Close to half of adults in the United States have hypertension (HTN), a major risk factor for coronary heart disease and stroke. Current guidelines recommend lifestyle change as a primary target in addressing HTN, including initiation of healthy diet and exercise. This review examines the evidence for nutrition and specific dietary factors (such as garlic), exercise, botanical medicines, and nutrients in the management of HTN. Lifestyle interventions and other integrative supports may have a strong impact on blood pressure control.
Get full access to this article
View all access options for this article.
References
1.
OstchegaY, FryarCD, NwankwoT, et al.Hypertension prevalence among adults aged 18 and Over: United States, 2017–2018 key findings data from the national health and nutrition examination survey. NCHS Data Brief, 2017; 1–8.
2.
BarbosaSS, SousaLCM, de Oliveira SilvaDF, et al.A systematic review on processed/ultra-processed foods and arterial hypertension in adults and older people. Nutrients, 2022; 14:1215.
3.
AronowWS. Drug-induced causes of secondary hypertension. Ann Transl Med, 2017; 5:349.
4.
BenowitzNL, BurbankAD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med, 2016; 26:515.
5.
CrippaG, BergonziM, BraviE, et al.Effect of electronic cigarette smoking on blood pressure in hypertensive patients. Evaluation by non-invasive continuous ambulatory blood pressure measurement. J Hypertens, 2018; 36:e4.
6.
FuchsFD, WheltonPK. High blood pressure and cardiovascular disease. Hypertension, 2020; 75:285–292.
7.
WangC, YuanY, ZhengM, et al.Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol, 2020; 75:2921–2930.
8.
RiedK, FrankOR, StocksNP. Aged garlic extract reduces blood pressure in hypertensives: A dose-response trial. Eur J Clin Nutr, 2013; 67:64–70.
9.
WHO. Guideline for the Pharmacological Treatment of Hypertension in Adults: Summary. 2022. Online document at: https://www.who.int/publications/i/item/9789240050969 Accessed July20, 2022.
10.
UngerT, BorghiC, CharcharF, et al.2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 2020; 75:1334–1357.
11.
HinderliterAL, SmithP, SherwoodA, et al.Lifestyle interventions reduce the need for guideline-directed antihypertensive medication. Am J Hypertens, 2021; 34:1100–1107.
12.
RichterCK, kulas-RayAC, Kris-EthertonPM. Recent findings of studies on the mediterranean diet: What are the implications for current dietary recommendations?. Endocrinol Metab Clin North Am, 2014; 43:963–980.
13.
FilippouCD, TsioufisCP, ThomopoulosCG, et al.Dietary approaches to stop hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: A systematic review and meta-analysis of randomized controlled trials. Adv Nutr, 2020; 11:1150–1160.
14.
JonesD. Dietary sodium and potassium intake. J Hypertens, 2019; 37:e252.
15.
JeongH, JinHS, KimSS, et al.Identifying interactions between dietary sodium, potassium, sodium–potassium ratios, and FGF5 rs16998073 variants and their associated risk for hypertension in Korean adults. Nutrients, 2020; 12:1–14.
16.
BalafaO, KalaitzidisRG. Salt sensitivity and hypertension. J Hum Hypertens 2020 353, 2020; 35:184–192.
17.
HeJ, HuangJF, LiC, et al.Sodium sensitivity, sodium resistance, and incidence of hypertension: A longitudinal follow-up study of dietary sodium intervention. Hypertension, 2021; 78:155–164.
18.
ChoiHY, ParkHC, HaSK. Salt sensitivity and hypertension: A paradigm shift from kidney malfunction to vascular endothelial dysfunction. Electrolytes Blood Press, 2015; 13:7–16.
19.
FelderRA, WhiteMJ, WilliamsSM, et al.Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens, 2013; 22:65.
20.
JenningsA, BerendsenAM, De GrootLCPGM, et al.Mediterranean-style diet improves systolic blood pressure and arterial stiffness in older adults: Results of a 1-year european multi-center trial. Hypertension, 2019; 73:578–586.
21.
FilippouCD, ThomopoulosCG, KouremetiMM, et al.Mediterranean diet and blood pressure reduction in adults with and without hypertension: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr, 2021; 40:3191–3200.
22.
SchwingshacklL, ChaimaniA, SchwedhelmC, et al.Comparative effects of different dietary approaches on blood pressure in hypertensive and pre-hypertensive patients: A systematic review and network meta-analysis. Crit Rev Food Sci Nutr, 2019; 59:2674–2687.
23.
CritselisE, KontogianniMD, GeorgousopoulouE, et al.Comparison of the Mediterranean diet and the dietary approach stop hypertension in reducing the risk of 10-year fatal and non-fatal CVD events in healthy adults: The ATTICA study (2002–2012). Public Health Nutr, 2021; 24:2746–2757.
24.
GaoX, XueZ, MaQ, et al.Antioxidant and antihypertensive effects of garlic protein and its hydrolysates and the related mechanism. J Food Biochem, 2020; 44:e13126.
25.
ChoudharyPR, JaniRD, SharmaMS. Effect of raw crushed garlic (Allium sativum L.) on components of metabolic syndrome. J Diet Suppl, 2018; 15:499–506.
26.
XiongXJ, WangPQ, LiSJ, et al.Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 2015; 22:352–361.
27.
RiedK. Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: An updated meta-analysis and review. J Nutr, 2016; 146:389S-396S.
28.
WichitsranoiJ, WeerapreeyakulN, BoonsiriP, et al.Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensive humans. Nutr J, 2011; 10:82.
29.
MiyawakiT, AonoH, Toyoda-OnoY, et al.Antihypertensive effects of sesamin in humans. J Nutr Sci Vitaminol (Tokyo), 2009; 55:87–91.
30.
Mahendra KumarC, SinghSA. Bioactive lignans from sesame (Sesamum indicum L.): Evaluation of their antioxidant and antibacterial effects for food applications. J Food Sci Technol, 2015; 52:2934.
31.
KaratziK, StamatelopoulosK, LykkaM, et al.Sesame oil consumption exerts a beneficial effect on endothelial function in hypertensive men. Eur J Prev Cardiol, 2013; 20:202.
32.
Rodriguez-LeyvaD, WeighellW, EdelAL, et al.Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension, 2013; 62:1081–1089.
33.
MassaroM, ScodittiE, CarluccioMA, et al.Effects of olive oil on blood pressure: Epidemiological, clinical, and mechanistic evidence. Nutrients, 2020; 12:1548.
34.
ZehrKR, WalkerMK. Omega-3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: A review. Prostaglandins Other Lipid Mediat, 2018; 134:131.
35.
ZhangX, RitonjaJA, ZhouN, et al.Omega-3 polyunsaturated fatty acids intake and blood pressure: A dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc, 2022; 11:25071.
36.
Carpio-RiveraE, Moncada-JiménezJ, Salazar-RojasW, et al.Acute effects of exercise on blood pressure: A meta-analytic investigation. Arq Bras Cardiol, 2016; 106:422–433.
37.
CornelissenVA, SmartNA. Exercise training for blood pressure: A systematic review and meta-analysis. J Am Heart Assoc, 2013; 2:e004473.
38.
LopesS, AfreixoV, TeixeiraM, et al.Exercise training reduces arterial stiffness in adults with hypertension: A systematic review and meta-analysis. J Hypertens, 2021; 39:214–222.
39.
Saco-LedoG, ValenzuelaPL, Ruiz-HurtadoG, et al.Exercise reduces ambulatory blood pressure in patients with hypertension: A systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc, 2020; 9:e018487.
40.
AnokwuruCP, EsiabaJ, AjibayeO, et al.Polyphenolic content and antioxidant activity of hibiscus sabdariffa calyx. Res J Med Plant, 2011; 5:557–566.
41.
SalemMA, EzzatSM, AhmedKA, et al.A comparative study of the antihypertensive and cardioprotective potentials of hot and cold aqueous extracts of Hibiscus sabdariffa L. in relation to their metabolic profiles. Front Pharmacol, 2022; 13:367.
42.
Herrera-ArellanoA, Miranda-SánchezJ, Ávila-CastroP, et al.Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med, 2007; 73:6–12.
43.
McKayDL, ChenCYO, SaltzmanE, et al.Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr, 2010; 140:298–303.
44.
Haji FarajiM, Haji TarkhaniAH. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol, 1999; 65:231–236.
45.
Herrera-ArellanoA, Flores-RomeroS, Chávez-SotoMA, et al.Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: A controlled and randomized clinical trial. Phytomedicine, 2004; 11:375–382.
46.
Mozaffari-KhosraviH, Jalali-KhanabadiBA, Afkhami-ArdekaniM, et al.The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Hum Hypertens, 2009; 23:48–54.
47.
SusalitE, AgusN, EffendiI, et al.Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with captopril. Phytomedicine, 2011; 18:251–258.
48.
HadiA, PourmasoumiM, GhaediE, et al.The effect of curcumin/turmeric on blood pressure modulation: A systematic review and meta-analysis. Pharmacol Res, 2019; 150:104505.
49.
KhajehdehiP, ZanjaninejadB, AflakiE, et al.Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study. J Ren Nutr, 2012; 22:50–57.
50.
AnandP, KunnumakkaraAB, NewmanRA, et al.Bioavailability of curcumin: Problems and promises. Mol Pharm, 2007; 4:807–818.
51.
GreenwayF, LiuZ, YuY, et al.A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides Oliver Bark extract to treat hypertension. Altern Med Rev, 2011; 16:338–348.
52.
ShekarrizZ, ShorofiSA, NabatiM, et al.Effect of Melissa officinalis on systolic and diastolic blood pressures in essential hypertension: A double-blind crossover clinical trial. Phytother Res, 2021; 35:6883–6892.
GrossmanE. Should melatonin be used to lower blood pressure?. Hypertens Res 2013 368, 2013; 36:682–683.
55.
CagnacciA, CannolettaM, RenziA, et al.Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens, 2005; 18:1614–1618.
56.
AhsanovaE, PopovV, BulanovaN, et al.Hypotensive action of melatonin in patients with arterial hypertension. Eur Cardiol Rev, 2020; 15:e43.
57.
ScheerFAJL, Van MontfransGA, Van SomerenEJW, et al.Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension, 2004; 43:192–197.
58.
LiL, LiL, ChaiJ-X, et al.Prevalence of poor sleep quality in patients with hypertension in china: A meta-analysis of comparative studies and epidemiological surveys. Front Psychiatry, 2020; 11:1.
59.
HadiA, GhaediE, MoradiS, et al.Effects of melatonin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Horm Metab Res, 2019; 51:157–164.
60.
OstadmohammadiV, SoleimaniA, BahmaniF, et al.The effects of melatonin supplementation on parameters of mental health, glycemic control, markers of cardiometabolic risk, and oxidative stress in diabetic hemodialysis patients: A randomized, double-blind, placebo-controlled trial. J Ren Nutr, 2020; 30:242–250.
61.
DiNicolantonioJJ, O'KeefeJH, WilsonW. Review: Subclinical magnesium deficiency: A principal driver of cardiovascular disease and a public health crisis. Open Hear, 2018; 5:668.
62.
ShafiqueM, AshrafM. Role of magnesium in the management of hypertension. J Pak Med Assoc, 1993; 43:77–78.
63.
HanH, FangX, WeiX, et al.Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: A systematic review and meta-analysis of prospective cohort studies. Nutr J, 2017; 16:26.
64.
ZhangX, LiY, Del GobboLC, et al.Effects of magnesium supplementation on blood pressure: A meta-analysis of randomized double-blind placebo-controlled trials. Hypertension, 2016; 68:324–333.
65.
RosanoffA, CostelloRB, JohnsonGH. Effectively prescribing oral magnesium therapy for hypertension: A categorized systematic review of 49 clinical trials. Nutrients, 2021; 13:1–15.
66.
TabriziR, AkbariM, SharifiN, et al.The effects of coenzyme Q10 supplementation on blood pressures among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev, 2018; 25:41–50.
67.
HoMJ, BellusciA, WrightJM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev, 2009; 4:CD007435.
68.
HoMJ, LiEC, WrightJM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev, 2016; 3:CD007435.
69.
WuCY, HuHY, ChouYJ, et al.High blood pressure and all-cause and cardiovascular disease mortalities in community-dwelling older adults. Medicine (Baltimore), 2015; 94:e2160.
